Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6192)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11088)
  2. Hematologic Malignancies, Division of (10639)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3722)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (310)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13546)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FDG PET/CT (FDG PET) in evaluation of response in patients with multiple myeloma (MM) treated with bortezomib, pegylated liposomal doxorubicin, and dexamethasone
    Meeting Abstract

    Pandit-Taskar, N.; Comenzo, R. L.; Hassoun, H.; Hoover, E.; Borkar, S.; Reidel, E.; Cohen, A.; Surti, C.; Nimer, S. D.; Landau, H. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • PROPEL: Results of the pivotal, multicenter, phase II study of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL)
    Meeting Abstract

    O'Connor, O.; Pro, B.; Pinter-Brown, L.; Popplewell, L.; Bartlett, N.; Lechowicz, M.; Savage, K.; Coiffier, B.; Saunders, M.; Horwitz, S.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Increased expression of androgen receptor (AR) and enzymes involved in androgen synthesis in metastatic prostate cancer: Targets for novel personalized therapies
    Meeting Abstract

    Mitsiades, N.; Schultz, N.; Taylor, B. S.; Hieronymus, H.; Satagopan, J.; Scardino, P. T.; Reuter, V. E.; Sander, C.; Sawyers, C.; Scher, H. I.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Late mortality and morbidity of patients with Hodgkin lymphoma treated in adulthood
    Meeting Abstract

    Matasar, M. J.; McCallen, L. N.; Riedel, E. R.; Ford, J. S.; Oeffinger, K. C.; Straus, D. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Elevated expression of VEGFR-2 and VEGFA in desmoplastic small round cell tumor (DSRCT) and activity of bevacizumab and irinotecan in a xenograft model of DSRCT
    Meeting Abstract

    Magnan, H. D.; Chou, T.; LaQuaglia, M. P.; Gerald, W.; Ladanyi, M.; Merchant, M. S.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in patients with light-chain amyloidosis (AL)
    Meeting Abstract

    Landau, H. J.; Hoffman, J.; Hassoun, H.; Elizabeth, H.; Riedel, E.; Nimer, S. D.; Cohen, A.; Comenzo, R. L.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Comparison of cisplatin (CDDP) and radiation (RT) to cetuximab (C) and RT for locally advanced head and neck cancer (LAHNC): A preliminary analysis
    Meeting Abstract

    Koutcher, L.; Fury, M.; Wolden, S.; Zhang, Z.; Mo, Q.; Zelefsky, M.; Kraus, D.; Sherman, E.; Pfister, D.; Lee, N.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • First-in-human phase I study of the novel structure proteasome inhibitor NPI-0052
    Meeting Abstract

    Hamlin, P. A.; Aghajanian, C.; Younes, A.; Hong, D. S.; Palladino, M. A.; Longenecker, A. M.; Lloyd, G. K.; Hannah, A. L.; Spear, M. A.; Kurzrock, R.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Prevalence of paroxysmal nocturnal hemoglobinuria (PNH) cells in patients with myelodysplastic syndromes (MDS), aplastic anemia (AA), or other bone marrow failure (BMF) syndromes: Interim results from the EXPLORE trial
    Meeting Abstract

    Galili, N.; Ravandi, F.; Palermo, G.; Bubis, J.; Illingworth, A.; Castro-Malaspina, H.; Raza, A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Therapeutic and palliative benefit from single-agent irinotecan in multiply treated and highly refractory cases of lymphoma
    Meeting Abstract

    Caces, D. D.; Halaas, J.; Hamlin, P.; Noy, A.; Kewalramani, T.; Portlock, C. S.; Zelenetz, A. D.; O'Connor, O. A.; Gerecitano, J. F.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save